Changes in cognitive appraisal in a randomized controlled trial of mindfulness-based cognitive therapy for patients with migraine

被引:2
|
作者
Kruse, Jessica A. [1 ,4 ]
Seng, Elizabeth K. [1 ,2 ,3 ]
机构
[1] Yesh Univ, Ferkauf Grad Sch Psychol, Bronx, NY USA
[2] Albert Einstein Coll Med, Saul R Korey Dept Neurol, Bronx, NY USA
[3] Montefiore Headache Ctr, Montefiore Med Ctr, Bronx, NY USA
[4] Yesh Univ, Ferkauf Grad Sch Psychol, 1165 Morris Pk Ave, Bronx, NY 10461 USA
来源
HEADACHE | 2023年 / 63卷 / 10期
关键词
metacognition; migraine; mindfulness; pain catastrophizing; BEHAVIORAL THERAPY; STRESS REDUCTION; CHRONIC PAIN; DISABILITY; FUSION; WOMEN; MODEL;
D O I
10.1111/head.14627
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
ObjectiveThis study is a secondary analysis evaluating changes in cognitive fusion and pain catastrophizing over 8 weeks of mindfulness-based cognitive therapy for migraine (MBCT-M) intervention versus waitlist/treatment as usual.BackgroundMigraine is a common disabling neurological condition. MBCT-M combines elements of cognitive behavioral therapy with mindfulness-based approaches and has demonstrated efficacy in reducing migraine-related disability.MethodsA total of 60 adults with migraine completed a 30-day run-in before randomization into a parallel design of either eight weekly individual MBCT-M sessions (n = 31) or waitlist/treatment as usual (n = 29): participants were followed for 1 month after. Participants completed the Pain Catastrophizing Scale (PCS) and the Cognitive Fusion Questionnaire (CFQ) at Months 0, 1, 2, and 4.ResultsThe PCS scores decreased more in the MBCT-M group (mean [SD] at baseline = 22.5 [9.6]; at Month 4 = 15.1 [8.8]) than in the waitlist/treatment as usual group (mean [SD] at baseline = 24.9 [9.0]; at Month 4 = 22.5 [10.4]) from Month 0 to 4 (beta = -7.24, p = 0.001, 95% confidence interval [CI] -11.39 to -3.09). The CFQ (mean [SD] baseline = 27.6 [8.0]; at Month 4 = 25.0 [8.0]) did not change significantly from Month 0 to 4 (beta = -1.2, p = 0.482, 95% CI -4.5 to 2.1). Parallel mediation analyses indicated that decreases in the PCS and CFQ together (beta = -6.1, SE = 2.5, 95% CI -11.6 to -1.8), and the PCS alone (beta = -4.8, SE = 2.04, 95% CI -9.1 to -1.1), mediated changes in headache disability in the MBCT-M treatment completer group (n = 19).ConclusionIn this study, pain catastrophizing showed strong promise as a potential mechanism of MBCT-M. Future research should continue to explore cognitive appraisal changes in mindfulness-based interventions.
引用
下载
收藏
页码:1403 / 1411
页数:9
相关论文
共 50 条
  • [41] Review: randomized controlled trials of Mindfulness-Based Stress reduction and mindfulness based cognitive therapy
    Fjorback, L. O.
    Rehfeld, E.
    Schroder, A.
    Arendt, M.
    Fink, P.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2008, 64 (06) : 650 - 650
  • [42] Cognitive therapy, mindfulness-based stress reduction, and behavior therapy for the treatment of chronic pain: randomized controlled trial
    Burns, John W.
    Jensen, Mark P.
    Thorn, Beverly
    Lillis, Teresa A.
    Carmody, James
    Newman, Andrea K.
    Keefe, Francis
    PAIN, 2022, 163 (02) : 376 - 389
  • [43] A Randomized Controlled Trial on the Efficacy of Mindfulness-Based Cognitive Therapy and a Group Version of Cognitive Behavioral Analysis System of Psychotherapy for Chronically Depressed Patients
    Michalak, Johannes
    Schultze, Martin
    Heidenreich, Thomas
    Schramm, Elisabeth
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2015, 83 (05) : 951 - 963
  • [44] Effectiveness of mindfulness-based cognitive therapy in patients with anxiety disorders in secondary-care settings: A randomized controlled trial
    Ninomiya, Akira
    Sado, Mitsuhiro
    Park, Sunre
    Fujisawa, Daisuke
    Kosugi, Teppei
    Nakagawa, Atsuo
    Shirahase, Joichiro
    Mimura, Masaru
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2020, 74 (02) : 132 - 139
  • [45] Mindfulness-Based Cognitive Therapy
    Heidenreich, Thomas
    Grober, Christoph
    Michalak, Johannes
    ZEITSCHRIFT FUR KLINISCHE PSYCHOLOGIE UND PSYCHOTHERAPIE, 2014, 43 (04): : 233 - 240
  • [46] Mindfulness-based cognitive therapy for adherence of immunosuppressive treatment in liver transplant recipients: A randomized controlled trial
    Bulbuloglu, Semra
    Gunes, Huseyin
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2024, 20 (05)
  • [47] Mindfulness-based cognitive therapy
    Hauge, Cecilie Tveteraas
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2015, 135 (01) : 51 - 51
  • [48] The efficacy of mindfulness-based cognitive therapy in recurrent depressed patients with and without a current depressive episode: a randomized controlled trial
    van Aalderen, J. R.
    Donders, A. R. T.
    Giommi, F.
    Spinhoven, P.
    Barendregt, H. P.
    Speckens, A. E. M.
    PSYCHOLOGICAL MEDICINE, 2012, 42 (05) : 989 - 1001
  • [49] Impact of Mindfulness-Based Cognitive Therapy on Depressive Symptoms Reduction among Depressed Patients in Nigeria: A Randomized Controlled Trial
    Musa, Zulkiflu Argungu
    Soh, Kim Lam
    Mukhtar, Firdaus
    Soh, Kwong Yan
    Oladele, Tajudeen Olalekan
    Soh, Kim Geok
    ISSUES IN MENTAL HEALTH NURSING, 2021, 42 (07) : 667 - 675
  • [50] Impact of mindfulness-based cognitive therapy on counseling self-efficacy: A randomized controlled crossover trial
    Chan, Sunny H. W.
    Yu, Calvin Kai-Ching
    Li, Alex W. O.
    PATIENT EDUCATION AND COUNSELING, 2021, 104 (02) : 360 - 368